CU Gynecologic Oncology Research
LightNews LightNews
banner
cugynonc.bsky.social
CU Gynecologic Oncology Research
@cugynonc.bsky.social
67 followers 95 following 37 posts
University of Colorado Anschutz gynecologic oncologists and researchers committed to advancing the future of women’s health. Focused on innovating early detection, prevention, and treatment through cutting-edge research. #GynOncology #CUAnschutz
Posts Replies Media Videos
cugynonc.bsky.social
Exciting news🎉 Courtney Bailey, a CU Anschutz Gates Institute Grubstake Award finalist and PhD student, will present her research "Macrophage Backpacks for Delivering Olaparib to #HGSCs" on Nov 20, 4–6 PM at CU Innovations Executive Conference Room in the AHSB. #CUGynOnc @courtneybailey.bsky.social
November 10, 2025 at 3:24 PM
cugynonc.bsky.social
Levi Watson, PhD, will be presenting on “Hematopoietic Stem Cell–Derived Adipocytes Influence the Ovarian Cancer Microenvironment” at the Ovarian Cancer Midwest Focus (OCMF) Conference in Minneapolis, MN, on November 10–11, 2025. For more information, visit: bit.ly/3JJy1oa

#CUAnschutz #GynOnc
November 5, 2025 at 9:39 PM
cugynonc.bsky.social
CU Gynecologic Oncology was proud to join the HERA Ovarian Cancer Foundation’s Climb4Life & Gala! 🌄 Dr. Kian Behbakht spoke at the event & Taylor Benson, PhD, shared her HERA-funded research on WNT4 and metabolic biomarkers in #ovariancancer. 💙

For more information: bit.ly/3Lg6aMP
#CUAnschutz
October 30, 2025 at 2:52 PM
cugynonc.bsky.social
✨Dr. Brad Corr, A CU Gynecologic Oncologist, is dispelling clinical trial myths! 🧪✅ Safe, innovative treatments empower patients to make informed care decisions.

📖 Read more: bit.ly/4hAKCGW 

#OvarianCancer #GynOnc #CUAnschutz
Debunking 8 Myths About Cancer Clinical Trials
Misunderstandings about cancer clinical trials – what they are and how they work – keep some people from accessing the life-saving treatments they offer.
bit.ly
October 27, 2025 at 6:14 PM
cugynonc.bsky.social
Join us for the Pharmacology Seminar Series as Dr. Elizabeth Woodruff discusses how chronic stress influences #HGSC progression and immune response through adrenergic signaling in the omentum. #OvarianCancer #GynOnc #CUAnschutz

Date 📅: Mon, 10/20/25, 12:00 PM MST
Location📍: RC1 North, Room 6107
October 16, 2025 at 4:51 PM
cugynonc.bsky.social
✨Dr. Christine Walsh, a leading Gynecologic Oncologist at the University of Colorado Anschutz, recently appeared on 9News to discuss genetics' role in gyn cancers as well as share insights on ovarian cancer.

👉 Watch the full interviews here: bit.ly/3KNj0lv 

#CancerGenetics #GynOc #CUAnschutz
Dr. Walsh with 9News
October 14, 2025 at 3:50 PM
cugynonc.bsky.social
Toni Moses, RN, is battling stage IV ovarian cancer while helping others—and participating in a trial led by Dr. Brad Corr & the CU Ovarian Cancer Innovations Group. 💙 Read her powerful story: news.cuanschutz.edu/cancer-cente...

#OvarianCancer #GynOnc #CUAnschutz
‘I Love What I Do’: While She Helps Patients, a Nurse Grapples with Her Own Ovarian Cancer
Toni Moses, RN, says she’s grateful to be enrolled in a clinical trial led by Bradley Corr, MD, of the CU Cancer Center.
news.cuanschutz.edu
October 1, 2025 at 7:16 PM
cugynonc.bsky.social
Thank you to all who attended the CU Ovarian Cancer Innovations Group (OCIG) Reception during the AACR Special Conference on #OvarianCancer! 💫 It was inspiring to connect with so many passionate researchers in Denver. Let’s keep the momentum going! #AACR #CUAnschutz
@uccc-gorg.bsky.social
September 23, 2025 at 4:04 PM
cugynonc.bsky.social
Congrats to Dr. Liz Woodruff (Division of Repro Science) on receiving a $10K Cancer Innovation Pilot Grant from
@cucancercenter.bsky.social!
Her study explores how social stress/isolation impacts high-grade serous carcinoma (HGSC) progression & immune response🎉 @liz-woodruff.bsky.social #CUAnschutz
September 23, 2025 at 3:00 PM
cugynonc.bsky.social
🎗️Attending the AACR Conference on Ovarian Cancer?

Visit Alan Elder’s poster "Discerning mechanisms of SEMA7A in therapy resistance & tumor progression in HGSC"

Also join the CU Ovarian Cancer Innovations Group (OCIG) Reception on Saturday, Sept 20th. Register here: bit.ly/47KvpA3

#AACRovca25
September 15, 2025 at 4:54 PM
cugynonc.bsky.social
🎉Dr. Kian Behbakht from CU's Ovarian Cancer Innovations Group (OCIG) was featured on #BBC The Happy Pod🎙️He discussed the development of an ovarian cancer early detection test, which is being developed in partnership with AOA Dx. #OvarianCancer #CUAnschutz

👉 Listen here: www.bbc.com/audio/play/p...
BBC Audio | Global News Podcast | The Happy Pod: The 'game changing' test for ovarian cancer
Happy stories and positive news from around the world - our weekly collection
www.bbc.com
September 8, 2025 at 8:24 PM
cugynonc.bsky.social
Drs. Ben Bitler & Kian Behbakht, AOA Dx (a women-owned Denver biotech), and other GynOnc researchers co-published a study on a scalable, sensitive test using lipidomic and protein biomarkers with machine learning to improve early ovarian cancer detection. View Here: www.mdpi.com/2075-4418/15...
www.mdpi.com
September 2, 2025 at 4:02 PM
cugynonc.bsky.social
Help us welcome Drs. Katharine Linder and Daisy Cruz, our new CU GynOnc fellows joining the University of Colorado GynOnc Research Group (GORG) Lab this Fall 2025! Excited for the expertise and passion they'll bring to advancing women’s cancer research 🎉🎉 #GynOnc #CUAnschutz #OvarianCancer
August 18, 2025 at 6:14 PM
cugynonc.bsky.social
🎉Dr. Lindsay Brubaker is tackling therapy resistance in #HGSC with cutting-edge research on antibody-drug conjugates (ADCs). Backed by a competitive DOD grant, her study explores epigenetic drivers to expand and improve treatment options. View Article bit.ly/4fxHr1E #OvarianCancer #CUAnschutz
August 11, 2025 at 4:48 PM
cugynonc.bsky.social
Congrats to Drs. Ben Bitler and Jim Lambert on receiving an award from Golfers Against Cancer to advance ovarian cancer immunogenic cell death (ICD) research — pushing boundaries in cancer research #OvarianCancer #GynOnc #CUAnschutz 👏👏 @uccc-gorg.bsky.social
August 5, 2025 at 7:35 PM
cugynonc.bsky.social
Congrats to Scott Lin, MD, PhD Candidate, on receiving the Cancer Biology T32 award from the National Cancer Institute! This prestigious award supports 5 predoctoral students each year with funding through the University of Colorado Cancer Center. 🎉🎉 #CUAnschutz #GynOnc @uccc-gorg.bsky.social
July 31, 2025 at 8:26 PM
cugynonc.bsky.social
🔬Don’t miss Session 2 of our gynecologic cancer virtual series! Scott Lin, MD, PhD Candidate, will share insights on PARP inhibitors & ovarian cancer treatment. #OvarianCancer @uccc-gorg.bsky.social

📅 Aug 11 |🕛 12–1PM MST |💻 Virtual
Topic: PARP Inhibitors
Register today! bit.ly/40k8dUE
June 25, 2025 at 7:17 PM
cugynonc.bsky.social
Congrats to Team Bitler—Drs. Bitler, Corr, Sikora, Clauset, and many others—2025 CU ASPIRE Awardees🎉Their SPORE effort to advance ovarian cancer care with novel therapies & population science. #OvarianCancer #CUAnschutz @uccc-gorg.bsky.social‬ @mjsikora.bsky.social View details here: Bit.ly/4mWBRsO
June 17, 2025 at 3:47 PM
cugynonc.bsky.social
Congratulations to Courtney Bailey, PhD student in Biomedical Engineering at CU Boulder and part of the Gynecologic Oncology Research Group at CU Anschutz! She was awarded the Achievement Reward for College Scientist Scholarship. Well deserved! 👏 #CUAnschutz #CUBoulder #BiomedicalEngineering #GynOnc
June 11, 2025 at 6:40 PM
cugynonc.bsky.social
Dr. Kian Behbakht and AOA Dx CEO Oriana Papin-Zoghbi spoke with 360Dx about the urgent need for better ovarian cancer diagnostics, highlighting how vague symptoms delay care and the role of innovation and data in closing this critical diagnostic gap. #OvarianCancer

👏Full article: bit.ly/3ZMxqa3
New Validation Data Shows Promise for AOA Dx Ovarian Cancer Early Detection Test
The firm presented data at AACR that showed the test had high accuracy when distinguishing ovarian cancer at early stages.
bit.ly
June 2, 2025 at 3:11 PM
cugynonc.bsky.social
Insights on IHC testing for clinical decision making - put together by our talented Gyn Onc Path team! Shout to Dr. Rebecca Wolsky.

@cucancercenter.bsky.social

www.sciencedirect.com/science/arti...
The evolving role of HER2 in gynecologic oncology and clinical trial design: A gynecologic pathologist's perspective
www.sciencedirect.com
May 24, 2025 at 8:04 PM
cugynonc.bsky.social
Join Computational Bioscience (CPBS) Program student Weishan Li for a talk on "Deriving Cell Type Specific Expression Profiles from HGSC using BuDDI"

Date 📅: Tomorrow (5/21/2025) 1PM MST
Location📍: RC1 North, Room 8108 & Zoom: ucdenver.zoom.us/j/9780564841...

#OvarianCancer #GynOnc #CUAnschutz
May 20, 2025 at 2:14 PM
cugynonc.bsky.social
Join Human Medical Genetics and Genomics Program (HMGGP) student Samantha Lopez Alvarez for a talk on "Evaluating Expression Based HRD Predictors in Black and White HGSC Patients"

When 📅: Today (5/15/2025) 1PM – 2:30PM MST
When📍: #CUAnschutz Hensel Phelps West Auditorium
#OvarianCancer
May 15, 2025 at 2:42 PM
cugynonc.bsky.social
At the 2025 #AACR Annual Meeting, AOA Dx shared new data showing >90% AUC in early #ovariancancer detection—outperforming CA125. This finding was made in collaboration with the #CU Ovarian Cancer Innovations Group & U. of Manchester. A big step for AI in women's health. Press Release: bit.ly/433cCft
AOA Dx Reports High Accuracy for AI-Powered Ovarian Cancer Blood Test in 1,000 Patient Study | Femtech Insider
AOA Dx, a company developing blood-based diagnostics for early cancer detection, has demonstrated high accuracy in detecting ovarian cancer in symptomatic women using its AI-powered multi-omic platfor...
bit.ly
May 14, 2025 at 3:22 PM
cugynonc.bsky.social
Today is World Ovarian Cancer Day #WOCD! In recognition of this important day, the CU Division of GynOnc will once again sponsor and participate in Jodi’s Race for Awareness 5k to support gyn cancers, including ovarian cancer, on 6/14/2025 in Denver. To register, please visit www.JodisRace.org
May 8, 2025 at 2:01 PM